isospaglumic acid has been researched along with levocabastine in 4 studies
| Studies (isospaglumic acid) | Trials (isospaglumic acid) | Recent Studies (post-2010) (isospaglumic acid) | Studies (levocabastine) | Trials (levocabastine) | Recent Studies (post-2010) (levocabastine) |
|---|---|---|---|---|---|
| 469 | 31 | 116 | 204 | 89 | 24 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Couturier, C; Goldschmidt, P; Haeffner-Cavaillon, N; Herman, D; Kazatchkine, M | 1 |
| Blondin, C; Cholley, B; Goldschmidt, P; Haeffner-Cavaillon, N | 1 |
| Bortolotti, M; Bremond-Gignac, D; Delval, L; Fregona, IA; Grouin, JM; Leonardi, A; Pouliquen, P; Violato, D | 1 |
| Colin, J; Hartani, D; Lazreg, S; Renault, D | 1 |
2 trial(s) available for isospaglumic acid and levocabastine
| Article | Year |
|---|---|
Clinical and biological efficacy of preservative-free NAAGA eye-drops versus levocabastine eye-drops in vernal keratoconjunctivitis patients.
Topics: Anti-Inflammatory Agents; Child; Conjunctivitis, Allergic; Dipeptides; Eosinophil Cationic Protein; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Lymphocyte Count; Male; Ophthalmic Solutions; Osmolar Concentration; Pilot Projects; Piperidines; Preservatives, Pharmaceutical; Tears; Treatment Outcome | 2007 |
[Intra-annual and seasonal allergic conjunctivitis treatment: comparison of two therapeutic protocols].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Allergic Agents; Child; Child, Preschool; Clinical Protocols; Conjunctivitis, Allergic; Dipeptides; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Male; Middle Aged; Piperidines; Prospective Studies; Seasons; Young Adult | 2008 |
2 other study(ies) available for isospaglumic acid and levocabastine
| Article | Year |
|---|---|
Effects of non-steroidal antiallergic eyedrops on the complement-mediated histamine release from human cells.
Topics: Allergens; Animals; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Basophil Degranulation Test; Basophils; Cell Degranulation; Complement C5; Cromolyn Sodium; Dipeptides; Enzyme-Linked Immunosorbent Assay; Histamine; Histamine H1 Antagonists; Histamine Release; Humans; Hypersensitivity, Immediate; Ophthalmic Solutions; Oxamic Acid; Piperidines; Recombinant Proteins | 1997 |
[In vitro effects of antiallergic eyedrops on complement activation induced by particulate matter].
Topics: Air Pollutants; Anti-Allergic Agents; Benzalkonium Compounds; Benzimidazoles; Complement Activation; Conjunctivitis; Cosmetics; Dibenzoxepins; Dipeptides; Drug Evaluation; Dust; Humans; In Vitro Techniques; Ketotifen; Nedocromil; Olopatadine Hydrochloride; Ophthalmic Solutions; Oxamic Acid; Phthalazines; Piperidines; Pollen; Silicon Dioxide; Zymosan | 2003 |